American Capital Advisory’s LeonaBio Inc LONA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.84K Hold
200
﹤0.01% 647
2026
Q1
$2.06K Hold
200
﹤0.01% 534
2025
Q4
$1.51K Hold
200
﹤0.01% 514
2025
Q3
$828 Hold
200
﹤0.01% 577
2025
Q2
$604 Hold
200
﹤0.01% 584
2025
Q1
$570 Hold
200
﹤0.01% 497
2024
Q4
$1.17K Hold
200
﹤0.01% 417
2024
Q3
$892 Buy
200
+100
+100% +$2.35K ﹤0.01% 415
2024
Q2
$2.43K Hold
100
﹤0.01% 345
2024
Q1
$2.5K Hold
100
﹤0.01% 359
2023
Q4
$2.43K Buy
+100
New +$1.77K ﹤0.01% 345

Other funds holding LONA

American Capital Advisory's LONA Position: Q2 2026 in Review

American Capital Advisory held its LeonaBio Inc (LONA) position steady in Q2 2026 at 200 shares worth $1.84K. The position accounts for ﹤0.01% of the portfolio, ranked #647.

American Capital Advisory first reported a position in LONA in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.5K in Q1 2024. 44 funds tracked by Wall St. Rank hold LONA as of Q2 2026.

  • American Capital Advisory held 200 shares of LeonaBio Inc worth $1.84K as of Q2 2026.
  • American Capital Advisory left its LeonaBio Inc share count unchanged in Q2 2026.
  • LeonaBio Inc made up ﹤0.01% of American Capital Advisory's portfolio in Q2 2026, its #647 holding.
  • American Capital Advisory first reported a position in LeonaBio Inc in Q4 2023 and has held it in 11 quarters since.
  • American Capital Advisory's LeonaBio Inc position peaked at $2.5K in Q1 2024.
  • 44 funds tracked by Wall St. Rank held LeonaBio Inc as of Q2 2026.

Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.